2021 - Distinguished Scientist Award, American Heart Association
2014 - Population Research Prize, American Heart Association
His primary areas of investigation include Internal medicine, Framingham Heart Study, Cardiology, Endocrinology and Framingham Risk Score. His is involved in several facets of Internal medicine study, as is seen by his studies on Risk factor, Heart failure, Blood pressure, Heart disease and Body mass index. His research investigates the link between Risk factor and topics such as Epidemiology that cross with problems in Intensive care medicine.
His Framingham Heart Study research incorporates themes from Proportional hazards model, Surgery, Cohort study, Stroke and Hazard ratio. His Cardiology study integrates concerns from other disciplines, such as Incidence and Systole. His Endocrinology research incorporates elements of Odds ratio and Offspring.
His primary scientific interests are in Internal medicine, Framingham Heart Study, Cardiology, Endocrinology and Framingham Risk Score. His Heart failure, Blood pressure, Risk factor, Hazard ratio and Body mass index study are his primary interests in Internal medicine. His research investigates the connection between Framingham Heart Study and topics such as Cohort study that intersect with issues in Genome-wide association study.
His study on Cardiology is mostly dedicated to connecting different topics, such as Confidence interval. Ramachandran S. Vasan combines topics linked to Natriuretic peptide with his work on Endocrinology. His studies deal with areas such as Offspring, Prospective cohort study, Odds ratio and Stroke as well as Framingham Risk Score.
His primary areas of study are Internal medicine, Framingham Heart Study, Cardiology, Disease and Heart failure. Internal medicine is closely attributed to Endocrinology in his research. His study looks at the intersection of Framingham Heart Study and topics like Body mass index with Obesity.
His studies in Cardiology integrate themes in fields like Pulse wave velocity, Heart rate, Arterial stiffness and Risk factor. Ramachandran S. Vasan combines subjects such as Young adult, Genome-wide association study, Bioinformatics and Subclinical infection with his study of Disease. His work carried out in the field of Heart failure brings together such families of science as Diastole, Myocardial infarction and Atrial fibrillation.
His main research concerns Internal medicine, Framingham Heart Study, Cardiology, Heart failure and Disease. All of his Internal medicine and Framingham Risk Score, Hazard ratio, Cohort, Cohort study and Dementia investigations are sub-components of the entire Internal medicine study. His biological study spans a wide range of topics, including Endocrinology and Incidence.
His Framingham Heart Study study combines topics in areas such as Epidemiology, Diabetes mellitus, Lower risk, Stroke and Brain size. His Cardiology study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
General Cardiovascular Risk Profile for Use in Primary Care The Framingham Heart Study
Ralph B. D’Agostino;Ramachandran S. Vasan;Michael J. Pencina;Philip A. Wolf.
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J Pencina;Ralph B D'Agostino;Ramachandran S Vasan.
Statistics in Medicine (2008)
Obesity and the Risk of Heart Failure
Satish Kenchaiah;Jane C Evans;Daniel Levy;Peter W F Wilson.
The New England Journal of Medicine (2002)
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.
Caroline S. Fox;Joseph M. Massaro;Udo Hoffmann;Karla M. Pou.
Vitamin D Deficiency and Risk of Cardiovascular Disease
Thomas J. Wang;Michael J. Pencina;Sarah L. Booth;Paul F. Jacques.
Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
Ramachandran S. Vasan;Martin G. Larson;Eric P. Leip;Jane C. Evans.
The New England Journal of Medicine (2001)
Long-term Trends in the Incidence of and Survival With Heart Failure
Daniel Levy;Satish Kenchaiah;Martin G Larson;Emelia J Benjamin.
The New England Journal of Medicine (2002)
The Progression From Hypertension to Congestive Heart Failure
Daniel Levy;Martin G. Larson;Ramachandran S. Vasan;William B. Kannel.
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.
Donald M. Lloyd-Jones;Thomas J. Wang;Thomas J. Wang;Eric P. Leip;Eric P. Leip;Martin G. Larson;Martin G. Larson.
Metabolite profiles and the risk of developing diabetes
Thomas J Wang;Thomas J Wang;Martin G Larson;Martin G Larson;Ramachandran S Vasan;Ramachandran S Vasan;Susan Cheng;Susan Cheng;Susan Cheng.
Nature Medicine (2011)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: